Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02081807 · ClinicalTrials.gov registry record
Sequential Expansion of Comparative Effectiveness of Anticoagulants
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 221,228
- Enrollment target
NCT02081807 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 221,228 participants.
The verdict
NCT02081807 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 221,228 participants
- Enrollment target
Study Summary
This cohort study is the sequential expansion of the comparative effectiveness study of oral anticoagulants and plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin and dabigatran) and the occurrence of selected outcomes in patients with non-valvular atrial fibrillation at risk for stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221,228 participants |
| Start Date | 2014-03-07 |
| Est. Completion | 2017-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02081807
The ClinicalTrials.gov registry entry for NCT02081807 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 221,228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02081807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02081807 about?
NCT02081807 is a clinical study titled "Sequential Expansion of Comparative Effectiveness of Anticoagulants". This cohort study is the sequential expansion of the comparative effectiveness study of oral anticoagulants and plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin and da...
What is the current status of trial NCT02081807?
This trial is currently completed. The enrollment target is 221,228 participants. The study started on 2014-03-07. Estimated completion is 2017-11-01.
Who is sponsoring clinical trial NCT02081807?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.